Compass Therapeutics Reports Q2 2026 Financial Results

What Happened
Compass Therapeutics, Inc. (CMPX) announced its financial results for the quarter and six months ended June 30, 2026 by issuing a press release on August 6, 2026. The company furnished that press release as Exhibit 99.1 to an 8-K (Item 2.02) filed the same day, reporting its recent operating and financial condition via the released statement.

Key Details

• Press release dated and issued on August 6, 2026 announcing Q2 2026 results and results for the six months ended June 30, 2026.
• Filing: Form 8-K dated August 6, 2026; Item reported: 2.02 (Results of Operations and Financial Condition).
• The press release was furnished as Exhibit 99.1 to the 8-K (Item 9.01(d) exhibit listing).
• The 8-K communicates the company’s quarterly earnings/financial results to investors; the full figures and commentary are in the furnished press release.

Why It Matters
This 8-K provides Compass Therapeutics’ latest quarterly results and a snapshot of its financial condition through June 30, 2026—information investors use to assess revenue, expenses, cash position, and near-term outlook. Review the furnished press release (Exhibit 99.1) for the specific revenue, profit/loss, cash and any management commentary or guidance, since those details can influence trading decisions and valuations.